全文获取类型
收费全文 | 674篇 |
免费 | 66篇 |
国内免费 | 25篇 |
专业分类
耳鼻咽喉 | 2篇 |
儿科学 | 31篇 |
妇产科学 | 13篇 |
基础医学 | 132篇 |
口腔科学 | 7篇 |
临床医学 | 66篇 |
内科学 | 175篇 |
皮肤病学 | 6篇 |
神经病学 | 77篇 |
特种医学 | 76篇 |
外科学 | 35篇 |
综合类 | 13篇 |
一般理论 | 1篇 |
预防医学 | 55篇 |
眼科学 | 1篇 |
药学 | 35篇 |
肿瘤学 | 40篇 |
出版年
2023年 | 3篇 |
2022年 | 2篇 |
2021年 | 23篇 |
2020年 | 12篇 |
2019年 | 12篇 |
2018年 | 26篇 |
2017年 | 14篇 |
2016年 | 21篇 |
2015年 | 15篇 |
2014年 | 25篇 |
2013年 | 27篇 |
2012年 | 35篇 |
2011年 | 55篇 |
2010年 | 31篇 |
2009年 | 25篇 |
2008年 | 27篇 |
2007年 | 49篇 |
2006年 | 38篇 |
2005年 | 16篇 |
2004年 | 16篇 |
2003年 | 22篇 |
2002年 | 17篇 |
2001年 | 12篇 |
2000年 | 9篇 |
1999年 | 15篇 |
1998年 | 18篇 |
1997年 | 25篇 |
1996年 | 16篇 |
1995年 | 18篇 |
1994年 | 11篇 |
1993年 | 14篇 |
1992年 | 2篇 |
1991年 | 6篇 |
1990年 | 6篇 |
1989年 | 22篇 |
1988年 | 14篇 |
1987年 | 8篇 |
1986年 | 18篇 |
1985年 | 5篇 |
1984年 | 3篇 |
1983年 | 4篇 |
1982年 | 5篇 |
1981年 | 1篇 |
1980年 | 3篇 |
1979年 | 2篇 |
1977年 | 9篇 |
1976年 | 5篇 |
1975年 | 1篇 |
1969年 | 1篇 |
1940年 | 1篇 |
排序方式: 共有765条查询结果,搜索用时 31 毫秒
11.
12.
Jakub Trizuljak Wolfgang R. Sperr Lucie Nekvindová Hanneke O. Elberink Karoline V. Gleixner Aleksandra Gorska Magdalena Lange Karin Hartmann Anja Illerhaus Massimiliano Bonifacio Cecelia Perkins Chiara Elena Luca Malcovati Anna B. Fortina Khalid Shoumariyeh Mohamad Jawhar Roberta Zanotti Patrizia Bonadonna Francesca Caroppo Alexander Zink Massimo Triggiani Roberta Parente Nikolas von Bubnoff Akif S. Yavuz Hans Hägglund Mattias Mattsson Jens Panse Nadja Jäkel Alex Kilbertus Olivier Hermine Michel Arock David Fuchs Vito Sabato Knut Brockow Agnes Bretterklieber Marek Niedoszytko Björn van Anrooij Andreas Reiter Jason Gotlib Hanneke C. Kluin-Nelemans Jiri Mayer Michael Doubek Peter Valent 《Allergy》2020,75(8):1927-1938
13.
Oude Nijhuis CS Daenen SM Vellenga E van der Graaf WT Gietema JA Groen HJ Kamps WA de Bont ES 《Critical reviews in oncology/hematology》2002,44(2):163-174
Cancer patients treated with chemotherapy are susceptible to bacterial infections. Therefore, all neutropenic cancer patients with fever receive standard therapy consisting of broad-spectrum antibiotics and hospitalization. However, febrile neutropenia in cancer patients is often due to other causes than bacterial infections. Therefore, standard therapy should be re-evaluated and new treatment strategies for patients with variable risk for bacterial infection should be considered. This paper reviews the changing spectrum of microorganisms and resistance of microorganisms to antibiotics in infection during neutropenia and discusses new strategies for the selection of patients with low-risk for bacterial infection using clinical and biochemical parameters such as acute phase proteins and cytokines. These low-risk patients may be treated with alternative therapies such as oral antibiotics, early discharge from the hospital or outpatient treatment. 相似文献
14.
Correction of liver disease by hepatocyte transplantation in a mouse model of progressive familial intrahepatic cholestasis 总被引:10,自引:0,他引:10
De Vree JM Ottenhoff R Bosma PJ Smith AJ Aten J Oude Elferink RP 《Gastroenterology》2000,119(6):1720-1730
BACKGROUND & AIMS: Patients with progressive familial intrahepatic cholestasis (PFIC) type 3 have a mutation in the MDR3 gene, encoding the hepatocanalicular phospholipid translocator. In general, liver failure develops within the first decade of life in these patients. Previous studies have shown that in the mdr2-knockout mouse, the animal model for this disease, the absence of phospholipids in bile causes chronic bile salt-induced damage to hepatocytes. We aimed to test the efficacy of hepatocyte transplantation and liver repopulation in this disease model. METHODS: Transgenic MDR3-expressing hepatocytes as well as normal mdr2(+/+) hepatocytes were transplanted in mdr2(-/-) mice, and liver repopulation was assessed by immunohistochemistry and measurement of biliary lipid secretion. RESULTS: Transplanted hepatocytes partially repopulated the liver, restored phospholipid secretion, and diminished liver pathology. Repopulation was stronger when hepatocellular damage was enhanced by a bile salt-supplemented diet. After 1 year, however, these animals developed multiple hepatic tumors, and biliary phospholipid secretion decreased. In transplanted animals receiving a control diet, repopulation was slower but eventually remained stable at 21%, while liver pathology was completely abrogated and tumor formation was prevented. CONCLUSIONS: These results suggest that moderate liver pathology is a safe condition for the induction of effective hepatocyte repopulation and that this therapy is potentially applicable to patients with PFIC type 3. 相似文献
15.
16.
17.
Atp8b1 deficiency in mice reduces resistance of the canalicular membrane to hydrophobic bile salts and impairs bile salt transport 总被引:7,自引:0,他引:7
Paulusma CC Groen A Kunne C Ho-Mok KS Spijkerboer AL Rudi de Waart D Hoek FJ Vreeling H Hoeben KA van Marle J Pawlikowska L Bull LN Hofmann AF Knisely AS Oude Elferink RP 《Hepatology (Baltimore, Md.)》2006,44(1):195-204
Progressive familial intrahepatic cholestasis type 1 (PFIC1, Byler disease, OMIM 211600) is a severe inherited liver disease caused by mutations in ATP8B1. ATP8B1 is a member of the type 4 subfamily of P-type ATPases, which are phospholipid flippases. PFIC1 patients generally develop end-stage liver disease before the second decade of life. The disease is characterized by impaired biliary bile salt excretion, but the mechanism whereby impaired ATP8B1 function results in cholestasis is unclear. In a mouse model for PFIC1, we observed decreased resistance of the hepatocanalicular membrane to hydrophobic bile salts as evidenced by enhanced biliary recovery of phosphatidylserine, cholesterol, and ectoenzymes. In liver specimens from PFIC1 patients, but not in those from control subjects, ectoenzyme expression at the canalicular membrane was markedly deficient. In isolated mouse livers Atp8b1 deficiency impaired the transport of hydrophobic bile salts into bile. In conclusion, our study shows that Atp8b1 deficiency causes loss of canalicular phospholipid membrane asymmetry that in turn renders the canalicular membrane less resistant toward hydrophobic bile salts. The loss of phospholipid asymmetry may subsequently impair bile salt transport and cause cholestasis. 相似文献
18.
Physical and functional interactions between Stat5 and the tyrosine- phosphorylated receptors for erythropoietin and interleukin-3 总被引:3,自引:1,他引:3
Erythropoietin (Epo) and interleukin-3 (IL-3) stimulate activation of the Jak2 tyrosine kinase and induce tyrosine phosphorylation and activation of Stat5. In the present study, we have shown that Epo or IL- 3 stimulation induces binding of Stat5 to the tyrosine-phosphorylated Epo receptor (EpoR) or IL-3 receptor beta subunit (betaIL3), respectively, in IL-3-dependent 32D cells expressing the EpoR. The binding of Stat5 to these cytokine receptors was shown to be rapid and transient, occurring within 1 minute of stimulation of cells and significantly decreasing after 5 minutes of cell treatment. In vivo binding experiments in COS cells showed that binding of Stat5 to the EpoR was mediated through the Stat5 Src homology 2 (SH2) domain. In vitro binding studies further showed that Stat5, but not other Stats examined, bound specifically to tyrosine-phosphorylated recombinant EpoR fusion proteins. In these in vivo and in vitro binding studies, Stat5 bound, albeit to a lesser degree, to truncated EpoR mutants in which all the intracellular tyrosines except Y-343 were removed. Furthermore, EpoR-derived synthetic phosphotyrosine peptides corresponding to Y-343, Y-401, Y-431, and Y-479 inhibited the in vitro binding of Stat5. When expressed in 32D cells, a mutant EpoR in which all the intracellular tyrosines were removed by carboxy-terminal truncation showed a significantly impaired ability to induce tyrosine phosphorylation of Stat5, particularly at low concentrations of Epo, but exhibited an increased sensitivity to Epo for growth signaling as compared with the wild-type EpoR. These results indicate that Stat5 specifically and transiently binds to the EpoR through the interaction between the Stat5 SH2 domain and specific phosphorylated tyrosines, including Y-343, in the EpoR cytoplasmic domain. It was implied that betaIL3 may also have similar Stat5 docking sites. The Stat5 docking sites in the EpoR were shown to facilitate specific activation of Stat5, which, however, may not be required for the EpoR-mediated growth signaling. 相似文献
19.
Seyed Mohammad Jazaeri Farsani Bas B. Oude Munnink Marta Canuti Martin Deijs Matthew Cotten Maarten F. Jebbink Joost Verhoeven Paul Kellam Katherine Loens Herman Goossens Margareta Ieven Lia van der Hoek 《Viruses》2015,7(1):239-251
Causative agents for more than 30 percent of respiratory infections remain unidentified, suggesting that unknown respiratory pathogens might be involved. In this study, antibody capture VIDISCA-454 (virus discovery cDNA-AFLP combined with Roche 454 high-throughput sequencing) resulted in the discovery of a novel type of rhinovirus C (RV-C). The virus has an RNA genome of at least 7054 nt and carries the characteristics of rhinovirus C species. The gene encoding viral protein 1, which is used for typing, has only 81% nucleotide sequence identity with the closest known RV-C type, and, therefore, the virus represents the first member of a novel type, named RV-C54. 相似文献
20.